Michael Tonroe
Vermögen: 5 437 $ am 31.05.2026
Vermögen: 5 437 $ am 31.05.2026
Michael Tonroe is currently Chief Financial Officer & Secretary at Dimerix Ltd. since 2026.
Mr. Tonroe is a Member of the Australian Institute of Co. Directors.
Mr. Tonroe is Secretary at Syngene Ltd. Former roles include Director at Sigtec Pty Ltd., CBQ No.
2 (UK) Ltd., and Lbm UK Ltd. Mr. Tonroe was Chief Financial Officer at Genetic Technologies Ltd. in 2021.
Mr. Tonroe was Chief Financial Officer & Co-Secretary at Opthea Ltd. from 2014 to 2021.
Mr. Tonroe was Secretary at Vegenics Pty Ltd. Mr. Tonroe was Chief Financial Officer & Secretary at Australian Synchrotron.
Mr. Tonroe was Chief Financial Officer & Secretary at Imugene Ltd. from 2022 to 2025.
Mr. Tonroe completed undergraduate studies at the University of Buckingham.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMUGENE LTD 0.02% | 30.06.2025 | 65’717 ( 0.02% ) | 5 437 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DIMERIX LIMITED | Finanzdirektor/CFO | 29.01.2026 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Syngene Ltd.
Syngene Ltd. Pharmaceuticals: MajorHealth Technology Holds licences for use of synthetic genetic molecules and their application as gene diagnostics or as antisense pharmaceuticals | Unternehmenssekretär | - |
| Unternehmen | Position | Ende |
|---|---|---|
| IMUGENE LIMITED | Finanzdirektor/CFO | 04.03.2025 |
| OPTHEA LIMITED | Finanzdirektor/CFO | 24.06.2021 |
| GENETIC TECHNOLOGIES LIMITED | Finanzdirektor/CFO | - |
Vegenics Pty Ltd.
Vegenics Pty Ltd. Medical/Nursing ServicesHealth Services Provides medical research, development and commercialization of biologics drugs | Unternehmenssekretär | - |
Lbm UK Ltd. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Genetic Technologies Ltd.
Genetic Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in affinity DNA, easy DNA and gene type testing activities | Commercial Services |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
University of Buckingham
University of Buckingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vegenics Pty Ltd.
Vegenics Pty Ltd. Medical/Nursing ServicesHealth Services Provides medical research, development and commercialization of biologics drugs | Health Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Syngene Ltd.
Syngene Ltd. Pharmaceuticals: MajorHealth Technology Holds licences for use of synthetic genetic molecules and their application as gene diagnostics or as antisense pharmaceuticals | Health Technology |
Sigtec Pty Ltd.
Sigtec Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Designs, develops and installation of intelligent transport systems | Commercial Services |
Dimerix Ltd.
Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
Australian Synchrotron | |
CBQ No. 2 (UK) Ltd.
CBQ No. 2 (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides foreign language training services | Commercial Services |
Lbm UK Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen